![]() |
市場調查報告書
商品編碼
1348455
無針接頭的全球市場:規模,佔有率,趨勢分析(2024年~2030年):MedCoreNeedleless Connector Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Hospital NLCs and Non-Hospital NLCs |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年,全球無針連接器市場規模預計將達到13.3億美元,較上年的12.6億美元成長5.8%。展望未來,預計將以4.5%的複合年增長率(CAGR)實現穩定成長,最終達到18億美元。值得注意的是,Becton Dickinson (BD) 和 ICU Medical 目前在全球無針連接器市場佔主導地位。
在接下來的預測期內,新興市場將受益於逐步轉向機械閥門設備。儘管用於機械瓣膜的無針連接器 (NLC) 的某些配置仍然存在一些問題,但其中大量已證明可改善患者的整體治療效果。儘管這些設備通常比分體式隔膜產品稍貴,但機械閥 NLC 的日益普及預計將在未來幾年對整體市場價值產生積極影響。
2023 年,Becton Dickinson (BD) 鞏固了其無針連接器 (NLC) 市場全球領導者的地位。該公司在廣闊的輸液治療市場中佔主導地位,增強了其品牌知名度以及以具有競爭力的價格大量生產和銷售各種一次性產品的能力。
ICU醫療在2023年穩居無針連接器市場第二名。在機械閥門連接器領域,ICU Medical 提供 Clave(TM) 連接器。Clave(TM) 連接器的創新設計將外部鈍插管無縫整合到分離式隔墊結構中,確保與任何標準公魯爾連接器相容。
無針連接器與各種其他一次性醫療保健產品一樣,可以以相對較低的成本製造和銷售。這為中小企業進入市場提供了動力,旨在提供與大公司相比更簡單、更具成本效益的產品。也就是說,能夠將 NLC 產品與其他輸液治療設備捆綁在一起的公司預計將在預測期內主導該市場。
本報告提供全球無針接頭市場相關調查,提供市場概要,以及各市場區隔,各地區趨勢,競爭情形等資訊。
In 2023, the worldwide needleless connector market exhibited a total worth of $1.33 billion, reflecting a 5.8% surge compared to the previous year's $1.26 billion. Projections for the upcoming period indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 4.5%, ultimately reaching $1.80 billion. Notably, Becton Dickinson (BD) and ICU Medical are currently the dominant players in the global needleless connector market.
Our comprehensive medical market research involved an extensive analysis of more than 15 intravenous set companies spanning seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts. The full report suite on the global intravenous sets market encompasses both hospital NLCs and non-hospital NLCs.
In the upcoming forecast period, emerging markets are set to reap the benefits of a gradual shift towards mechanical valve devices. Although certain configurations of mechanical valve needleless connectors (NLCs) raise some concerns, a significant number of them have proven their capability to enhance overall patient outcomes. Even though these devices typically come with a slightly higher price tag compared to split septum products, the increasing adoption of mechanical valve NLCs is expected to yield a favorable impact on the overall market's value in the years to come.
In 2023, Becton Dickinson (BD) solidified its position as the global leader in the Needleless Connector (NLC) market. Notably, Becton Dickinson also functions as an infusion pump manufacturer, leveraging this capability to bundle NLCs with its devices. The company maintains a commanding presence in the broader infusion therapy market, bolstering both its brand recognition and the ability to manufacture and market various disposable products in significant quantities at competitive prices.
Securing the second position in the global NLC market in 2023 was ICU Medical. In the realm of mechanical valve connectors, ICU Medical offers the Clave™ connector. The Clave™ connector's innovative design seamlessly integrates the external blunt cannula into the split septum structure, ensuring compatibility with any standard male Luer connector.
Needleless connectors, much like various other disposable healthcare products, can be produced and sold at relatively low costs. This aspect serves as an incentive for smaller companies to enter the market, aiming to provide simpler and more cost-effective products compared to their larger counterparts. Nonetheless, throughout the forecast period, the dominant players in this market are expected to be those capable of bundling NLC products with other infusion therapy devices.